Directory Image
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.

Cold Laser Therapy Market to Develop Rapidly by 2027

Author: Omkar Abhang
by Omkar Abhang
Posted: Nov 27, 2017

Light therapy is used since many years as a treatment modality for various pathological conditions. Cold laser therapy also known as low level laser therapy (LLLT) reduces pain, improves wound healing, regenerates nerves and relives muscle tension. The cold laser therapy offers all these advances over pharmaceuticals and the associated side effects. One of the first scientist to discover the advantage of light was Dr. Endre Mester who first studied the irradiation effect on rats. After this, he treated wounds on rat and observed accelerated healing effect. These few advantages of photobiomodulation introduced a new treatment option and an alternative to pharmaceuticals and its associated side effects. Cold laser therapy also known by the name photobiomodulation and phototherapy uses light energy from light emitting diode or lasers to elicit biological or cellular responses in the body.

Request for TOC @

https://www.futuremarketinsights.com/toc/rep-gb-3639

Cold Laser Therapy Market: Drivers & Restraints

Cold laser therapy has developed a lot of applications in the field of healthcare. The clinical application of laser therapy in the field of healthcare is already extraordinary. Cold laser therapy has already proved it efficiency in tendon strains, chronic back pain, cold sores, burns and strokes and are used regularly in many clinics. Moreover, the increasing prevalence rate of cancer has also made cold laser therapy a new treatment option in the field of clinical research.

Cold Laser Therapy Market: Overview

Light therapy works on various cell processes to simulate the release of cellular energy which is used to facilitate the restoration of normal cell function and morphology. Moreover, the reimbursement policies for cold laser therapy is also emerging. Currently, 97026, S8948 codes are used in relation to cold laser therapy as there are no established CPT codes for cold laser therapy.

Cold Laser Therapy Market: Region-wise Outlook

Regionally the report covers market scenario in North America, Europe, Asia Pacific, Latin America and MEA. North America cold laser therapy market leads with the amount of research undertakings and many market player introducing technological advance minimally invasive therapies. Erchonia Corporation’s ZERONA is a newly developed non-invasive body-sculpting procedure which allows patient to continue daily activities eliminating surgery pain and wounds.

Request to view Sample Report:

https://www.futuremarketinsights.com/reports/sample/rep-gb-3639

Asia Pacific is the fastest growing region as cold laser therapy is yet to be explored in this region. There are number of research undertaking and newer discoveries of the advantages of light therapy. In Australia around four million people suffer from debilitating chronic pain. Recent clinical trials in the country have established the advantages of using cold laser therapy for the same.

Cold Laser Therapy Market:

Some of the players in cold laser therapy market are Erchonia Corporation, BioLight Technologies LLC, Theralase Inc, THOR Photomedicine, Apira Science Inc., Quantumpm and B-Cure laser Australia.

About the Author

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousand

Rate this Article
Leave a Comment
Author Thumbnail
Please or Join to add a comment.
Author: Omkar Abhang

Omkar Abhang

Flag of United States
United States

Member since: Nov 20, 2017
Published articles: 513

Related Articles